Teva Pharmaceutical Industries Ltd. (TEVA)
32.47
-0.32
(-0.98%)
USD |
NYSE |
Jan 13, 16:00
31.97
-0.50
(-1.54%)
Pre-Market: 08:59
Teva Pharmaceutical Industries Market Cap: 37.25B for Jan. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 174.63B |
| Novo Nordisk A/S | 265.01B |
| Compugen Ltd. | 184.26M |
| Pfizer Inc. | 143.00B |
| Can-Fite BioPharma Ltd. | 3.534M |
Market Cap Related Metrics
| PE Ratio | 52.95 |
| PS Ratio | 2.220 |
| Price to Book Value | 5.138 |
| Price to Free Cash Flow | 149.21 |
| Price | 32.47 |
| Earnings Yield | 1.89% |
| Operating PE Ratio | 10.41 |
| Normalized PE Ratio | 19.55 |